Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 7
2020 8
2021 11
2022 7
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity.
Sagan SA, Moinfar Z, Moseley CE, Dandekar R, Spencer CM, Verkman AS, Ottersen OP, Sobel RA, Sidney J, Sette A, Anderson MS, Steinman L, Wilson MR, Sabatino JJ Jr, Zamvil SS. Sagan SA, et al. Proc Natl Acad Sci U S A. 2023 Jul 25;120(30):e2306572120. doi: 10.1073/pnas.2306572120. Epub 2023 Jul 18. Proc Natl Acad Sci U S A. 2023. PMID: 37463205 Free PMC article.
Defining blood-induced microglia functions in neurodegeneration through multiomic profiling.
Mendiola AS, Yan Z, Dixit K, Johnson JR, Bouhaddou M, Meyer-Franke A, Shin MG, Yong Y, Agrawal A, MacDonald E, Muthukumar G, Pearce C, Arun N, Cabriga B, Meza-Acevedo R, Alzamora MDPS, Zamvil SS, Pico AR, Ryu JK, Krogan NJ, Akassoglou K. Mendiola AS, et al. Nat Immunol. 2023 Jul;24(7):1173-1187. doi: 10.1038/s41590-023-01522-0. Epub 2023 Jun 8. Nat Immunol. 2023. PMID: 37291385 Free PMC article.
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses.
Novak F, Bajwa HM, Coia JE, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Hvidt MVM, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ Jr, Sejbaek T. Novak F, et al. J Neurol Neurosurg Psychiatry. 2023 Nov;94(11):934-937. doi: 10.1136/jnnp-2022-330757. Epub 2023 Apr 25. J Neurol Neurosurg Psychiatry. 2023. PMID: 37185261 Free PMC article. Clinical Trial.
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab.
Bennett JL, Fujihara K, Kim HJ, Marignier R, O'Connor KC, Sergott RC, Traboulsee A, Wiendl H, Wuerfel J, Zamvil SS, Anania VG, Buffels R, Künzel T, Lekkerkerker AN, Lennon-Chrimes S, Pittock SJ. Bennett JL, et al. Front Neurol. 2023 Feb 17;14:1114667. doi: 10.3389/fneur.2023.1114667. eCollection 2023. Front Neurol. 2023. PMID: 36873431 Free PMC article.
CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity.
Gupta S, Simic M, Sagan SA, Shepherd C, Duecker J, Sobel RA, Dandekar R, Wu GF, Wu W, Pak JE, Hauser SL, Lim W, Wilson MR, Zamvil SS. Gupta S, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Jan 19;10(2):e200080. doi: 10.1212/NXI.0000000000200080. Print 2023 Mar. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36657993 Free PMC article.
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators.
Sabatino JJ Jr, Mittl K, Rowles W, Zamecnik CR, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Alexander J, Mcpolin K, Chen P, Deshpande C, Wyse K, Maiese EM, Wilson MR, Zamvil SS, Bove R. Sabatino JJ Jr, et al. Mult Scler Relat Disord. 2023 Feb;70:104484. doi: 10.1016/j.msard.2022.104484. Epub 2022 Dec 28. Mult Scler Relat Disord. 2023. PMID: 36608538 Free PMC article.
Neuronal deletion of MnSOD in mice leads to demyelination, inflammation and progressive paralysis that mimics phenotypes associated with progressive multiple sclerosis.
Bhaskaran S, Kumar G, Thadathil N, Piekarz KM, Mohammed S, Lopez SD, Qaisar R, Walton D, Brown JL, Murphy A, Smith N, Saunders D, Beckstead MJ, Plafker S, Lewis TL Jr, Towner R, Deepa SS, Richardson A, Axtell RC, Van Remmen H. Bhaskaran S, et al. Redox Biol. 2023 Feb;59:102550. doi: 10.1016/j.redox.2022.102550. Epub 2022 Nov 26. Redox Biol. 2023. PMID: 36470129 Free PMC article.
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients.
Bajwa HM, Novak F, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Witt AH, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. Bajwa HM, et al. Mult Scler Relat Disord. 2022 Apr;60:103729. doi: 10.1016/j.msard.2022.103729. Epub 2022 Mar 6. Mult Scler Relat Disord. 2022. PMID: 35334278 Free PMC article.
38 results